Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew G Johnson

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 10, 2022
Creation of a Multispecialty Clinic for Patients with Central Sensitization-Based Chronic Pain ConditionsConor G Loftus, Jon O Ebbert, Christopher A Aakre, et al.
Clinical Trials (London, England)|March 3, 2025
Impact of differences between interim and post-interim analysis populations on outcomes of a group sequential trial: Example of the MOVe-OUT studyYoseph Caraco, Matthew G Johnson, Joseph A Chiarappa, et al.
Microbiology Spectrum|February 1, 2024
Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT)Matthew G Johnson, Julie M Strizki, Erin Jensen, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 6, 2023
Population pharmacokinetics of molnupiravir in adults with COVID-19: Lack of clinically important exposure variation across individualsSébastien Bihorel, Youfang Cao, Akshita Chawla, et al.
NEJM Evidence|February 6, 2024
Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized AdultsYoseph Caraco, Gordon E Crofoot, Pablo Andres Moncada, et al.
Systematic Biology|December 12, 2018
A Universal Probe Set for Targeted Sequencing of 353 Nuclear Genes from Any Flowering Plant Designed Using k-Medoids ClusteringMatthew G Johnson, Lisa Pokorny, Steven Dodsworth, et al.
Immunity|October 21, 2016
Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and Promotes InfectionMark R Cronan, Rebecca W Beerman, Allison F Rosenberg, et al.
The New England Journal of Medicine|December 16, 2021
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized PatientsAngélica Jayk Bernal, Monica M Gomes da Silva, Dany B Musungaie, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2020
The uncharacterized gene <i>EVE</i> contributes to vessel element dimensions in <i>Populus</i>Cíntia L Ribeiro, Daniel Conde, Kelly M Balmant, et al.
Science (New York, N.Y.)|April 27, 2023
Insights into mammalian TE diversity through the curation of 248 genome assembliesAustin B Osmanski, Nicole S Paulat, Jenny Korstian, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 10, 2022
Creation of a Multispecialty Clinic for Patients with Central Sensitization-Based Chronic Pain ConditionsConor G Loftus, Jon O Ebbert, Christopher A Aakre, et al.
Clinical Trials (London, England)|March 3, 2025
Impact of differences between interim and post-interim analysis populations on outcomes of a group sequential trial: Example of the MOVe-OUT studyYoseph Caraco, Matthew G Johnson, Joseph A Chiarappa, et al.
Microbiology Spectrum|February 1, 2024
Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT)Matthew G Johnson, Julie M Strizki, Erin Jensen, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 6, 2023
Population pharmacokinetics of molnupiravir in adults with COVID-19: Lack of clinically important exposure variation across individualsSébastien Bihorel, Youfang Cao, Akshita Chawla, et al.
NEJM Evidence|February 6, 2024
Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized AdultsYoseph Caraco, Gordon E Crofoot, Pablo Andres Moncada, et al.
Systematic Biology|December 12, 2018
A Universal Probe Set for Targeted Sequencing of 353 Nuclear Genes from Any Flowering Plant Designed Using k-Medoids ClusteringMatthew G Johnson, Lisa Pokorny, Steven Dodsworth, et al.
Immunity|October 21, 2016
Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and Promotes InfectionMark R Cronan, Rebecca W Beerman, Allison F Rosenberg, et al.
The New England Journal of Medicine|December 16, 2021
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized PatientsAngélica Jayk Bernal, Monica M Gomes da Silva, Dany B Musungaie, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2020
The uncharacterized gene <i>EVE</i> contributes to vessel element dimensions in <i>Populus</i>Cíntia L Ribeiro, Daniel Conde, Kelly M Balmant, et al.
Science (New York, N.Y.)|April 27, 2023
Insights into mammalian TE diversity through the curation of 248 genome assembliesAustin B Osmanski, Nicole S Paulat, Jenny Korstian, et al.
Pageof 11